By Richard Blackden - Daily Telegraph's US Business Editor 

A jackpot of $250m (£161m) is the sort of figure that creates long queues at lottery machines on Saturday mornings. But Greg Thorpe does not sound like someone who has discovered he is in line to share up to a quarter of a billion dollars with three others.

The 61 year-old did not buy a winning ticket. Instead, he’s one of four former employees of GlaxoSmithKline whose evidence earlier this month helped the US Department of Justice (DoJ) impose a record $3bn fine on Britain’s biggest drugmaker, for mis-marketing medicines to patients in America. The father of four has lived the past 10 years as a whistleblower.

“To tell you the truth, it’s still emotionally draining,” Thorpe told The Daily Telegraph. “I’m trying to look ahead.” It is understandable that such a long legal battle should still frame life for one of the first sales representatives that Glaxo hired when it pushed into the US in 1978. On July 3, Glaxo admitted publicly to practices that Thorpe, who worked for the company in the mid-western city of Denver for more than 20 years, first complained of to his managers in 2001.

This article can be found in its entirety on the Telegraph website.